The 27 references in paper M. Bolotin V., A. Lopatin V., М. Болотин В., А. Лопатин В. (2015) “СОВРЕМЕННЫЕ ПОДХОДЫ К ЛЕЧЕНИЮ НЕРАБДОИДНЫХ САРКОМ МЯГКИХ ТКАНЕЙ ГОЛОВЫ И ШЕИ У ДЕТЕЙ (ОБЗОР ЛИТЕРАТУРЫ) // CURRENT APPROACHES TO TREATING NON-RHABDOID SOFT TISSUE SARCOMAS OF THE HEAD AND NECK IN CHILDREN: A REVIEW OF LITERATURE” / spz:neicon:ogsh:y:2012:i:2:p:92-96

1
Ferrari A., Casanova M. Specification on the definition of adult-type soft tissue sarcoma. J Clin Oncol 2006;24(24):4042−3.
(check this in PDF content)
2
Grovas A., Fremgen A., Rauck A. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997;80:2321−32.
(check this in PDF content)
3
Gurney J.G., Smith M.A., Ross J.A. SEER Cancer incidence and survival among children and adolescents: United States SEER Program 1975−1995. National Institutes of Health: 99-4649.
(check this in PDF content)
4
Cancer Epidemiology in Older Adolescents and Young Adults 1975−2000. National Institutes of Health: 06-5767.
(check this in PDF content)
5
Rao B.N. Nonrhabdomyosarcoma in children: prognostic factors influencing survival. Semin Surg Oncol 1993;9(6):524−31.
(check this in PDF content)
6
Spunt S.L., Poquette C.A., Hurt Y.S. et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol 1999; 17(12):3697−705.
(check this in PDF content)
7
Andrassy R.J. Advances in the surgical management of sarcomas in children. Am J Surg 2002;184(6):484−91.
(check this in PDF content)
8
Hayes-Jordan A.A., Spunt S.L., Poquette C.A. et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? J Pediatr Surg 2000; 35(6):948−54.
(check this in PDF content)
9
Ferrari A., Casanova M., Collini P. et al. Adult-type soft tissue sarcomas in pediatricage patients: experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 2005 June 20; 23(18):4021−30.
(check this in PDF content)
10
Rao B.N., Etcubanas E.E., Green A.A. Present-day concepts in the management of sarcomas in children. Cancer Invest 1989; 7(4):349−56.
(check this in PDF content)
11
Dillon P.W., Maurer H., Jenkins J. et al. A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. J Pediatr Surg 1992;27:241−5.
(check this in PDF content)
12
Pappo A.S., Rao B.N., Jenkins J. et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children’s Research Hospital experience. Med Pediatr Oncol 1999; 33(2):76−82.
(check this in PDF content)
13
Rao B.N. Nonrhabdomyosarcoma in children: prognostic factors influencing survival. Semin Surg Oncol 1993; 9(6):524−31.
(check this in PDF content)
14
Andrassy R.J. Advances in the surgical management of sarcomas in children. Am J Surg 2002;184(6):484−91.
(check this in PDF content)
15
Paulino A.C., Ritchie J., Wen B.C. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer 2004; 43:587−93.
(check this in PDF content)
16
Mark R.J., Poen J., Tran L.M. et al. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer 1994; 73(10):2653−62.
(check this in PDF content)
17
Kuttesch J.F. Jr, Wexler L.H., Marcus R.B. et al. Second malignancies after Ewing’s sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996; 14(10):2818−25.
(check this in PDF content)
18
Hawkins M.M. Second primary tumors following radiotherapy for childhood cancer. Int J Radiat Oncol Biol Phys 1990 Nov;
(check this in PDF content)
19
5):1297−301. 19. Meadows A.T. Second malignant neoplasms in childhood cancer survivors. J Assoc Pediatr Oncol Nurses 1989; 6(1):7−11.
(check this in PDF content)
20
Pratt C.B., Pappo A.S., Gieser P. et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol 1999;17(4):1219−26.
(check this in PDF content)
21
Yang J.C., Chang A.E., Baker A.R. et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197−203.
(check this in PDF content)
22
Ferrari A. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft tissue sarcomas. Expert Rev Anticancer Ther 2008; 8(6);929−38.
(check this in PDF content)
23
Pappo A.S., Devidas M., Jenkins J. et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advancedstage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol 2005;23(18): 4031−7.
(check this in PDF content)
24
Nathan P.C., Tsokos M., Long L. et al. Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience. Pediatr Blood Cancer 2005; 44(5):449−54.
(check this in PDF content)
25
Daw N.C., Billups C.A., Pappo A.S. et al. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children’s Research Hospital experience. Cancer 2003;97(11): 2839−47.
(check this in PDF content)
26
Wan X., Helman L.J. The biology behind mTOR inhibition in sarcoma. Oncologist 2007;12:1007−18.
(check this in PDF content)
27
Heymach J.V. Angiogenesis and antiangiogenic approaches to sarcomas. Curr Opin Oncol 2001;12:261−9.
(check this in PDF content)